The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.
Korobka V.L.
FGBOU VO «Rostovskij gosudarstvennyj meditsinskij universitet» Minzdrava Rossii, Rostov-na-Donu
Pak E.S.
Rostov Regional Clinical Hospital, Rostov Region, Rostov-on-Don, Russia;
Rostov State Medical University, Ministry of Health of the Russia, Rostov-on-Don, Russia
Pasechnikov V.D.
Kostrykin M.Yu.
Rostov Regional Clinical Hospital, Rostov Region, Rostov-on-Don, Russia
Compensation of HCV-associated decompensated cirrhosis treated with modern direct-acting antiviral agents
Journal: Russian Journal of Evidence-Based Gastroenterology. 2019;8(4): 11‑21
Views: 4055
Downloaded: 70
To cite this article:
Korobka VL, Pak ES, Pasechnikov VD, Kostrykin MYu. Compensation of HCV-associated decompensated cirrhosis treated with modern direct-acting antiviral agents. Russian Journal of Evidence-Based Gastroenterology.
2019;8(4):11‑21. (In Russ.)
https://doi.org/10.17116/dokgastro2019804-05111
Aim. To assess the efficacy of the direct-acting antiviral agents (DAA) in patients with decompensated HCV-associated liver cirrhosis. Material and methods. A retrospective case-control study was conducted. Case cohort enrolled ten adults with HCV-associated decompensated liver cirrhosis included in the waiting list for liver transplantation. These patients were delisted after DAA therapy due to recompensation of liver cirrhosis. Control cohort comprised of 32 patients with HCV–associated decompensated liver cirrhosis included in the waiting list for the same period. Subcompensation of liver cirrhosis developed in these patients. Results. Administration of DAA (combination of sofosbuvir, daclatasvir and ribavirin) for 12 and 24 weeks (in patients with contraindications for ribavirin) resulted in a sustained virologic response in 100% cases in both cohorts. Antiviral therapy significantly reduced MELD and Child—Turcotte—Pugh values in patients with recompensation of liver cirrhosis. Moreover, significant decrease of the international normalized ratio, blood bilirubin, alkaline phosphatase, Na, improvement of platelet and leukocyte levels were observed in this cohort of patients. Conclusion. The study showed the possibility of recompensation of HCV-associated liver cirrhosis after DAA administration. Antiviral therapy significantly reduced MELD and Child—Turcotte—Pugh values and improved liver function tests.
Keywords:
Authors:
Korobka V.L.
FGBOU VO «Rostovskij gosudarstvennyj meditsinskij universitet» Minzdrava Rossii, Rostov-na-Donu
Pak E.S.
Rostov Regional Clinical Hospital, Rostov Region, Rostov-on-Don, Russia;
Rostov State Medical University, Ministry of Health of the Russia, Rostov-on-Don, Russia
Pasechnikov V.D.
Kostrykin M.Yu.
Rostov Regional Clinical Hospital, Rostov Region, Rostov-on-Don, Russia
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.